Form 8-K - Current report:
SEC Accession No. 0000950170-25-089972
Filing Date
2025-06-25
Accepted
2025-06-25 16:26:46
Documents
19
Period of Report
2025-06-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K revb-20250623.htm   iXBRL 8-K 109770
2 EX-99.1 revb-ex99_1.htm EX-99.1 16168
3 GRAPHIC img220778470_0.jpg GRAPHIC 61154
4 GRAPHIC img220778470_1.jpg GRAPHIC 319579
5 GRAPHIC img220778470_2.jpg GRAPHIC 105898
6 GRAPHIC img220778470_3.jpg GRAPHIC 80517
7 GRAPHIC img220778470_4.jpg GRAPHIC 91187
8 GRAPHIC img220778470_5.jpg GRAPHIC 107605
9 GRAPHIC img220778470_6.jpg GRAPHIC 167655
10 GRAPHIC img220778470_7.jpg GRAPHIC 43567
  Complete submission text file 0000950170-25-089972.txt   1620266

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20250623.xsd EX-101.SCH 47760
21 EXTRACTED XBRL INSTANCE DOCUMENT revb-20250623_htm.xml XML 6769
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)